BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Pharmaceuticals

Worldwide Markets for Blood Disorder Treatments  

Report Code: PHM039A, Published: June 2004

 

Click here for the latest version of this report - PHM039B

 

REPORT HIGHLIGHTS

  • For 2003, the total worldwide market for blood disorder treatments was estimated at $25.4 billion. Rising at an average annual growth rate (AAGR) of 6.7%, the market is expected to exceed $35 billion by 2008.
  • The prescription anemia pharmaceutical treatment segment accounts for the largest portion of revenues, with $10 billion in 2003 but is growing at a slower pace than the overall market, at 5.9%.
  • Prescription thrombosis treatments, the second largest segment, will account for about $12.3 billion in 2008, up from $9.2 billion in 2003.
  • Rising the fastest are treatments for neutropenia at an AAGR of 9%, and will reach nearly $4.6 billion in 2008.

Report Code: PHM039A, Published: June 2004, Analyst: Mary Anne Crandall

 
 

   Bookmark and Share


   


All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map